Medicus Pharma Stock Price Prediction
| MDCX Stock | 3.95 0.25 6.76% |
Oversold Vs Overbought
41
Oversold | Overbought |
EPS Estimate Current Year (1.50) | Wall Street Target Price 5.61 | EPS Estimate Current Quarter (0.11) |
Using Medicus Pharma hype-based prediction, you can estimate the value of Medicus Pharma from the perspective of Medicus Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medicus Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Medicus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medicus Pharma after-hype prediction price | CAD 3.55 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medicus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medicus Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medicus Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Medicus Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medicus Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medicus Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medicus Pharma Estimiated After-Hype Price Volatility
In the context of predicting Medicus Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medicus Pharma's historical news coverage. Medicus Pharma's after-hype downside and upside margins for the prediction period are 0.18 and 18.60, respectively. We have considered Medicus Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medicus Pharma is extremely dangerous at this time. Analysis and calculation of next after-hype price of Medicus Pharma is based on 3 months time horizon.
Medicus Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medicus Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medicus Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medicus Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.00 | 15.05 | 0.40 | 0.02 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.95 | 3.55 | 10.13 |
|
Medicus Pharma Hype Timeline
Medicus Pharma is now traded for 3.95on TSX Venture Exchange of Canada. The entity has historical hype elasticity of -0.4, and average elasticity to hype of competition of -0.02. Medicus is forecasted to decline in value after the next headline, with the price expected to drop to 3.55. The average volatility of media hype impact on the company price is over 100%. The price drop on the next news is expected to be -10.13%, whereas the daily expected return is now at 1.0%. The volatility of related hype on Medicus Pharma is about 71666.67%, with the expected price after the next announcement by competition of 3.93. The company recorded a loss per share of 1.25. Medicus Pharma had not issued any dividends in recent years. The entity had 1:2 split on the 25th of October 2024. Assuming the 90 days trading horizon the next forecasted press release will be in about 4 days. Check out Medicus Pharma Basic Forecasting Models to cross-verify your projections.Medicus Pharma Related Hype Analysis
Having access to credible news sources related to Medicus Pharma's direct competition is more important than ever and may enhance your ability to predict Medicus Pharma's future price movements. Getting to know how Medicus Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medicus Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AAPL | Apple Inc CDR | 0.28 | 1 per month | 1.02 | 0.06 | 2.09 | (2.19) | 6.39 | |
| NVDA | NVIDIA CDR | (0.01) | 1 per month | 1.94 | 0.04 | 4.03 | (3.17) | 9.09 | |
| MSFT | Microsoft Corp CDR | 0.21 | 1 per month | 1.46 | (0.02) | 1.99 | (1.71) | 7.96 | |
| AMZN | Amazon CDR | 0.00 | 0 per month | 1.28 | 0.12 | 2.82 | (2.61) | 10.08 | |
| GOOG | Alphabet Inc CDR | (0.85) | 1 per month | 1.29 | 0.13 | 2.91 | (1.93) | 8.61 | |
| META | Meta Platforms CDR | 0.00 | 0 per month | 1.27 | 0.10 | 3.14 | (1.87) | 8.24 | |
| TSLA | Tesla Inc CDR | 0.13 | 1 per month | 2.28 | 0.21 | 8.04 | (3.95) | 27.76 | |
| BRK | Berkshire Hathaway CDR | 0.00 | 0 per month | 0.86 | (0.07) | 1.22 | (1.52) | 7.22 | |
| AVGO | Broadcom | 0.03 | 3 per month | 1.51 | 0.12 | 4.28 | (3.19) | 9.42 | |
| WMT | Walmart Inc CDR | 0.00 | 0 per month | 0.90 | 0.15 | 1.84 | (1.67) | 4.95 |
Medicus Pharma Additional Predictive Modules
Most predictive techniques to examine Medicus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medicus using various technical indicators. When you analyze Medicus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medicus Pharma Predictive Indicators
The successful prediction of Medicus Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medicus Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medicus Pharma based on analysis of Medicus Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medicus Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medicus Pharma's related companies.
Story Coverage note for Medicus Pharma
The number of cover stories for Medicus Pharma depends on current market conditions and Medicus Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medicus Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medicus Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medicus Pharma Short Properties
Medicus Pharma's future price predictability will typically decrease when Medicus Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medicus Pharma often depends not only on the future outlook of the potential Medicus Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medicus Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.2 M |
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.